Visual, Pregnancy Hcg, Prescription Use(JHI)
視覚判定式妊娠診断用hCGキット(処方箋用) この日本語名は AI が生成した参考訳です。正式名称は英語の原名です。
43 件
直近 2024.11.06
375 件
0 件
3,857 件
分類情報
| Product Code | JHI |
|---|---|
| デバイス名 | Visual, Pregnancy Hcg, Prescription Use 視覚判定式妊娠診断用hCGキット(処方箋用) この日本語名は AI が生成した参考訳です。正式名称は英語の原名です。 |
| デバイスクラス | クラス II |
| 21 CFR 規制番号 | 862.1155 |
| 審査区分 | 510(k)(市販前届出) |
| 医療専門分野 | 臨床化学 |
| 定義 | - |
| フラグ | 該当なし |
| AI分析 | この機器は米国においてクラスIIに分類されており、市販前届出(510(k))による審査を経て市販が認められます。クラスIIは中程度のリスクを有する医療機器区分であり、市販前承認(PMA)のような厳格な審査ではなく、既存の同等性機器との比較に基づく510(k)手続きにより安全性・有効性が確認される仕組みとなっています。 米国市場での動向 本製品コードでは、510(k)による届出が累計約380件あり、申請企業は約160社に上りますが、直近5年間の届出は約2件にとどまっています。不具合報告は累計約3,800件で、大半が不具合(Malfunction)によるものであり、死亡1件、傷害は約200件報告されています。主な問題としてFalse Positive Result(偽陽性結果)、False Negative Result(偽陰性結果)、High Test Results(高値の検査結果)が挙げられています。回収は累計約40件で、クラスIは確認されておらず、クラスIIが約10件、クラスIIIが1件となっており、直近5年間では約10件、最新の回収は2024年8月に開始されています。 この分析は公開データ(openFDA・JMDN 対応情報)をもとに AI が生成した参考情報です。市場データは2026年8月時点の集計に基づきます。 |
関連 product code
同じ 21 CFR 862.1155 に分類される product code(5 件)
| No. | product code | 機器名 | クラス | 専門分野 | 510(k) | PMA | 不具合 | 回収 |
|---|---|---|---|---|---|---|---|---|
| 1 | LCX | Kit, Test, Pregnancy, Hcg, Over The Counter 妊娠検査用キット(尿中hCG測定、一般用) | II | 臨床化学 | 226 | — | 236 | 25 件 |
| 2 | JHJ | Agglutination Method, Human Chorionic Gonadotropin 凝集法ヒト絨毛性ゴナドトロピン測定キット | II | 臨床化学 | 96 | — | 171 | 3 件 |
| 3 | DHA | System, Test, Human Chorionic Gonadotropin ヒト絨毛性ゴナドトロピン試験システム | II | 臨床化学 | 72 | — | 3,595 | 14 件 |
| 4 | NAL | Test, Immunoassay, Biosensor, Hcg バイオセンサー式ヒト絨毛性ゴナドトロピン免疫測定装置 | II | 臨床化学 | 2 | — | 16 | — |
| 5 | LFS | Radioreceptor Assay, Human Chorionic Gonadotropin ヒト絨毛性ゴナドトロピン放射受容体測定装置 | II | 臨床化学 | — | — | 4 | — |
機器名の日本語訳は AI により自動生成したものです。正確には英語原文をご確認ください。
FDA のデバイスクラスは 3 段階(クラス I〜III)、日本の医療機器は 4 段階(クラス I〜IV)で分類されており、 1 対 1 では対応しません。 リスク区分の考え方が異なるため、参考情報としてご利用ください。
米国での回収・承認・不具合報告
米国回収
全 43 件| 回収番号 | クラス | 回収開始日 | 企業 | 理由 | ステータス |
|---|---|---|---|---|---|
| Z-0259-2025 JHI | クラス II | 2024.08.23 | Princeton Biomeditech Corp | This recall was initiated due to customer complaints of false negative of hCG test results when running patient urine samples. Use of the above listed product lot may result in false negative results. An end user reported that the OSOM Ultra hCG Combo Test, lot 563L13, produced false negative test results from 2 patient urine samples as confirmed by quantitative hCG and ultrasound. During further root cause testing and investigation, an additional 6 devices were found to produce false negative test results from hCG positive samples. | 対応中 |
| Z-0065-2024 JHI | クラス II | 2023.05.22 | Universal Meditech Inc. | Universal Meditech Inc. was violatively distributing PrestiBio" Breastmilk Alcohol Test Strip, DiagnosUS¿ SARS-CoV-2 Antibody (IgG/IgM) Test, HealthyWiser KetoFast" Ketone Test Strips and PrestiBio" Ketone Test Strips without marketing authorization. UMI is also recall their tests because they are going out of business and would not be able to continue fulfilling any post-market responsibilities of these distributed products. UMI claims to hold 510(k)s for the other devices, purchased the intellectual property in 2015 from the previous 510(k) holder, but FDA has been unable to verify this information. The devices may have unknown performance characteristics because the firm is unable to provide any documentation that the devices were manufactured in conformance with the Quality System regulation, including documentation (e.g., DHF) that the distributed devices had not been modified since original clearance in a way that could impact their safety and effectiveness, documentation of controlled storage temperature/humidity, and post-market surveillance documentation, such as complaints and adverse events. | 対応中 |
| Z-0064-2024 JHI | クラス II | 2023.05.22 | Universal Meditech Inc. | Universal Meditech Inc. was violatively distributing PrestiBio" Breastmilk Alcohol Test Strip, DiagnosUS¿ SARS-CoV-2 Antibody (IgG/IgM) Test, HealthyWiser KetoFast" Ketone Test Strips and PrestiBio" Ketone Test Strips without marketing authorization. UMI is also recall their tests because they are going out of business and would not be able to continue fulfilling any post-market responsibilities of these distributed products. UMI claims to hold 510(k)s for the other devices, purchased the intellectual property in 2015 from the previous 510(k) holder, but FDA has been unable to verify this information. The devices may have unknown performance characteristics because the firm is unable to provide any documentation that the devices were manufactured in conformance with the Quality System regulation, including documentation (e.g., DHF) that the distributed devices had not been modified since original clearance in a way that could impact their safety and effectiveness, documentation of controlled storage temperature/humidity, and post-market surveillance documentation, such as complaints and adverse events. | 対応中 |
| Z-0063-2024 JHI | クラス II | 2023.05.22 | Universal Meditech Inc. | Universal Meditech Inc. was violatively distributing PrestiBio" Breastmilk Alcohol Test Strip, DiagnosUS¿ SARS-CoV-2 Antibody (IgG/IgM) Test, HealthyWiser KetoFast" Ketone Test Strips and PrestiBio" Ketone Test Strips without marketing authorization. UMI is also recall their tests because they are going out of business and would not be able to continue fulfilling any post-market responsibilities of these distributed products. UMI claims to hold 510(k)s for the other devices, purchased the intellectual property in 2015 from the previous 510(k) holder, but FDA has been unable to verify this information. The devices may have unknown performance characteristics because the firm is unable to provide any documentation that the devices were manufactured in conformance with the Quality System regulation, including documentation (e.g., DHF) that the distributed devices had not been modified since original clearance in a way that could impact their safety and effectiveness, documentation of controlled storage temperature/humidity, and post-market surveillance documentation, such as complaints and adverse events. | 対応中 |
| Z-0061-2024 JHI | クラス II | 2023.05.22 | Universal Meditech Inc. | Universal Meditech Inc. was violatively distributing PrestiBio" Breastmilk Alcohol Test Strip, DiagnosUS¿ SARS-CoV-2 Antibody (IgG/IgM) Test, HealthyWiser KetoFast" Ketone Test Strips and PrestiBio" Ketone Test Strips without marketing authorization. UMI is also recall their tests because they are going out of business and would not be able to continue fulfilling any post-market responsibilities of these distributed products. UMI claims to hold 510(k)s for the other devices, purchased the intellectual property in 2015 from the previous 510(k) holder, but FDA has been unable to verify this information. The devices may have unknown performance characteristics because the firm is unable to provide any documentation that the devices were manufactured in conformance with the Quality System regulation, including documentation (e.g., DHF) that the distributed devices had not been modified since original clearance in a way that could impact their safety and effectiveness, documentation of controlled storage temperature/humidity, and post-market surveillance documentation, such as complaints and adverse events. | 対応中 |
| Z-0050-2024 JHI | クラス II | 2023.05.22 | Universal Meditech Inc. | Universal Meditech Inc. was violatively distributing PrestiBio" Breastmilk Alcohol Test Strip, DiagnosUS¿ SARS-CoV-2 Antibody (IgG/IgM) Test, HealthyWiser KetoFast" Ketone Test Strips and PrestiBio" Ketone Test Strips without marketing authorization. UMI is also recall their tests because they are going out of business and would not be able to continue fulfilling any post-market responsibilities of these distributed products. UMI claims to hold 510(k)s for the other devices, purchased the intellectual property in 2015 from the previous 510(k) holder, but FDA has been unable to verify this information. The devices may have unknown performance characteristics because the firm is unable to provide any documentation that the devices were manufactured in conformance with the Quality System regulation, including documentation (e.g., DHF) that the distributed devices had not been modified since original clearance in a way that could impact their safety and effectiveness, documentation of controlled storage temperature/humidity, and post-market surveillance documentation, such as complaints and adverse events. | 対応中 |
| Z-0048-2024 JHI | クラス II | 2023.05.22 | Universal Meditech Inc. | Universal Meditech Inc. was violatively distributing PrestiBio" Breastmilk Alcohol Test Strip, DiagnosUS¿ SARS-CoV-2 Antibody (IgG/IgM) Test, HealthyWiser KetoFast" Ketone Test Strips and PrestiBio" Ketone Test Strips without marketing authorization. UMI is also recall their tests because they are going out of business and would not be able to continue fulfilling any post-market responsibilities of these distributed products. UMI claims to hold 510(k)s for the other devices, purchased the intellectual property in 2015 from the previous 510(k) holder, but FDA has been unable to verify this information. The devices may have unknown performance characteristics because the firm is unable to provide any documentation that the devices were manufactured in conformance with the Quality System regulation, including documentation (e.g., DHF) that the distributed devices had not been modified since original clearance in a way that could impact their safety and effectiveness, documentation of controlled storage temperature/humidity, and post-market surveillance documentation, such as complaints and adverse events. | 対応中 |
| Z-1606-2022 JHI | クラス II | 2022.05.25 | Mckesson Medical-Surgical Inc. Corporate Office | Facility Temperature excursions (from June 2021-August 2021) prior to delivery; exposure to higher temperatures may have impacted product effectiveness. All lots received between 06/01/21-9/30/21. | 対応中 |
| Z-1587-2022 JHI | クラス II | 2022.05.25 | Mckesson Medical-Surgical Inc. Corporate Office | Facility Temperature excursions (from June 2021-August 2021) prior to delivery; exposure to higher temperatures may have impacted product effectiveness. All lots received between 06/01/21-9/30/21. | 対応中 |
| Z-2083-2018 JHI | クラス II | 2018.03.05 | Tosoh Bioscience Inc | Asfotase Alfa (Strensiq) interferes with certain Tosoh assays which potentially causes falsely increased or falsely decreased immunoassay test results, depending upon the assay. | 終了 |
| Z-2391-2018 JHI | クラス II | 2016.10.20 | Ekla Corporation | Incorrect hCG results | 終了 |
| Z-1401-2013 JHI | クラス II | 2013.04.16 | Alere San Diego, Inc. | The firm initiated recall of Alere" hCG Combo Cassette (20/10 mIU/mL) kit PN 92215, lots hCG1110133 and hCG1110135, because an investigation has indicated a portion of these Alere" hCG Combo Cassette (20/10 mIU/mL) PN 92215 kit lots were incorrectly packaged with the Alere" hCG Cassette (20 mIU/mL) PN 92210 Product Insert. The Alere" hCG Cassette (20 mIU/mL) Product Insert contains information for | 終了 |
| Z-1344-2013 JHI | クラス III(軽微) | 2013.01.21 | Alere San Diego, Inc. | Alere San Diego Inc. is recalling the Cardinal Health hCG Cassette Rapid Test because some of them were incorrectly packaged into Cardinal Health hCG Combo Rapid test kit boxes. The kit box incorrectly indicates the product may be used for both urine and serum sample types. | 終了 |
| Z-1736-2011 JHI | - | - | - | - | - |
| Z-1715-2008 JHI | - | - | - | - | - |
| Z-1475-2008 JHI | - | - | - | - | - |
| Z-1457-2011 JHI | - | - | - | - | - |
| Z-1436-04 JHI | - | - | - | - | - |
| Z-1399-05 JHI | - | - | - | - | - |
| Z-1392-05 JHI | - | - | - | - | - |
510(k)(市販前届出)
全 375 件| No. | 番号 | 機器名 | 申請者 | 決定日 | 種別 | 概要 |
|---|---|---|---|---|---|---|
| 1 | K241919 | Innovita HCG Pregnancy Rapid Combo Test | Innovita (Tangshan) Biological Technology Co., Ltd. | 2024.08.02 | 通常(Traditional) | |
| 2 | K203272 | Alltest Pregnancy Rapid Combo Test Cassette | Hangzhou AllTest Biotech Co., Ltd. | 2022.01.31 | 通常(Traditional) | |
| 3 | K172322 | Atellica IM Total hCG (ThCG) | Siemens Healthcare Diagnostics, Inc. | 2018.03.29 | 通常(Traditional) | |
| 4 | K172257 | TrueDX hCG Early Result Pregnancy Test (Midstream Format), TrueDX hCG Early Result Pregnancy Test (Cassette Format), VeriClear Early Result Pregnancy Test (Midstream Format), VeriClear Early Result Pregnancy Test (Cassette Format) | True Diagnostics, Inc. | 2017.12.22 | 通常(Traditional) | |
| 5 | K152768 | Assure Tech hCG Pregnancy Serum/Urine Combo Test Cassette, Assure Tech hCG Pregnancy Serum/Urine Combo Test Strip | Assure Tech. Co., Ltd. | 2016.02.24 | 通常(Traditional) | |
| 6 | K130456 | WUNDER PREGNANCY TEST | James Nguyen | 2014.04.08 | 通常(Traditional) | |
| 7 | K132834 | FASTEP S10 HCG SERUM/URINE COMBO TEST | Polymed Therapeutics, Inc. | 2014.01.09 | 通常(Traditional) | |
| 8 | K131166 | SOFIA(R) HCG FIA | Quidel Corp. | 2013.08.02 | 通常(Traditional) | |
| 9 | K123844 | CHEMTRUE HCG PREGNANCY URINE DIPSTICK, HCG PREGNANCY URINE CASSETTE TEST, AND HCG COMBO SERUM/URINE CASSETTE TEST | Chemtron Biotech, Inc. | 2013.05.30 | 通常(Traditional) | |
| 10 | K112101 | FASTEP HCG PREGANCY SERUM/URINE CASSETTE AND DIPSTICK TESTS | Polymed Therapeutics, Inc. | 2012.07.17 | 通常(Traditional) | |
| 11 | K112315 | HOME PREGNANCY TEST | Newscen Coast Bio-Pharmaceutical Co., Ltd. | 2012.04.23 | 通常(Traditional) | |
| 12 | K102175 | RAPIDVUE HCG TEST | Quidel Corporation | 2010.08.25 | 特別(Special) | |
| 13 | K072264 | FASTPACK HCG IMMUNOASSAY | Qualigen, Inc. | 2007.12.06 | 通常(Traditional) | |
| 14 | K071030 | BIONEXIA HCG PREGNANCY SERUM/URINE CASSETTE AND DIPSTICK TESTS, MODELS 08-HCGC AND 02-HCGC | Applied Dna Technologies, Inc. | 2007.06.29 | 通常(Traditional) | |
| 15 | K070921 | BIONEXIA HCG PREGNANCY CASSETTE AND DIPSTICK TESTS, MODEL 08-HCG AND 02-HCG | Applied Dna Technologies, Inc. | 2007.06.29 | 通常(Traditional) | |
| 16 | K061257 | DBEST HCG PANEL TEST KIT | Ameritek USA, Inc. | 2007.05.04 | 通常(Traditional) | - |
| 17 | K062361 | INNOVACON HCG UKTRA TEST DEVICE | Innovacon, Inc. | 2006.10.23 | 通常(Traditional) | |
| 18 | K050955 | LIFESIGN DXPRESS, MODEL LSR2000 | Princeton BioMeditech Corp. | 2006.01.23 | 通常(Traditional) | |
| 19 | K052694 | ONE STEP HCG PREGNANCY TEST - 2000 MIU/ML, MODEL 100 SERIES. | Ind Diagnostic, Inc. | 2005.12.16 | 通常(Traditional) | - |
| 20 | K051841 | WH ACCU TEST ONE-STEP URINE/SERUM COMBO PREGNANCY TEST | W.H.P.M., Inc. | 2005.08.22 | 通常(Traditional) |
出典の openFDA は各 510(k) の主要(primary)product code のみを収録しているため、副次コードを含む FDA 公式データベースの検索結果とは件数が異なる場合があります。 FDA 510(k) データベースで確認
PMA(市販前承認)
この product code の PMA 情報はありません。
不具合報告(MAUDE)トレンド
米国不具合報告検索で詳しく見る出典: openFDA(U.S. FDA) のデータをそのまま掲載しています。内容の正確性・最新性は保証されません。FDA が本サイトの内容を承認・保証するものではありません。
報告の存在は、機器と事象の因果関係を意味しません。報告件数を機器間の不具合発生率の比較に用いることはできません。
各データセット(510(k)・PMA・MAUDE・回収・Warning Letter)の解説は 米国FDA情報の概要 を参照してください。
出典: openFDA(U.S. FDA) のデータをそのまま掲載しています。内容の正確性・最新性は保証されません。FDA が本サイトの内容を承認・保証するものではありません。
取得日: 2026.09.28
各データセット(510(k)・PMA・MAUDE・回収・Warning Letter)の解説は 米国FDA情報の概要 を参照してください。